Centany is a drug owned by Padagis Us Llc. It is protected by 1 US drug patent filed in 2013 out of which all have expired. Based on its patents and exclusivities, its generic launch date is estimated to be Jul 08, 2018. Details of Centany's patents and their expiration are given in the table below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| These drug patents focus on the other aspects of the drug like dosage, mode of administration (oral, tablet, capsules, liquids etc). | |||
| US6013657 | Pharmaceutical compositions containing mupirocin |
Jul, 2018
(6 years ago) |
Expired
|
US patents provide insights into the exclusivity only within the United States, but Centany is protected by patents in multiple countries. Understanding the full scope of patent protection is crucial in strategizing market entry. By looking at the broader patent landscape, you can identify markets with weaker patent protection which could be ideal generic entry points. The following section offers details on Centany's family patents as well as insights into ongoing legal events on those patents.
Centany's Family Patents
Explore Our Curated Drug Screens
Generic Launch
Generic Release Date:
Centany's generic launch date based on the expiry of its last outstanding patent is estimated to be Jul 08, 2018 (This date is subject to change depending upon the patent filing activities by the drug owner or exclusivity additions to its drug application)
Centany Generic API suppliers:
Mupirocin is the generic name for the brand Centany. 5 different companies have already filed for the generic of Centany, with Fougera Pharms having the maximum number of approved applications. Check out the entire list of companies who have already received approval for Centany's generic
Alternative Brands for Centany
There are several other brand drugs using the same active ingredient (Mupirocin) as Centany. Given below is the list of those companies and their brand drugs, to help you identify new opportunities, assess competitors, and plan your market strategies more effectively.
| Drug Owner | Drug Name | |
|---|---|---|
| Glaxosmithkline |
|
Apart from brand drugs containing the same ingredient, some generics have also been filed for Mupirocin, Centany's active ingredient. Check the complete list of approved generic manufacturers for Centany
About Centany
Centany is a drug owned by Padagis Us Llc. Centany uses Mupirocin as an active ingredient. Centany was launched by Padagis Us in 2002.
Approval Date:
Centany was approved by FDA for market use on 04 December, 2002.
Active Ingredient:
Centany uses Mupirocin as the active ingredient. Check out other Drugs and Companies using Mupirocin ingredient
Dosage:
Centany is available in ointment form for topical use. Given below is detailed information on Dosage -
| Strength | Dosage Form | Availability | Application Pathway |
|---|---|---|---|
| 2% | OINTMENT | Prescription | TOPICAL |